LYKALABS

Lyka Labs Share PriceLyka Labs

₹93.9
0.95 (1.02%)
As on 29 May, 2023 | 20:40 BSE: 500259 NSE: LYKALABS

Lyka Labs Performance

Day Range

  • Low
  • High
93.9

52 Week Range

  • Low
  • High
93.9
  • Open Price
  • Previous Close
  • Volume

Start SIP in Lyka Labs

Start SIP

Lyka Labs Share Price

  • Over 1 Month -8.88%
  • Over 3 Month -17.31%
  • Over 6 Month -34.9%
  • Over 1 Year -22.46%

Lyka Labs Key Statistics

P/E Ratio -23.4
PEG Ratio 0.2
Market Cap Cr 311
Price to Book Ratio 6.8
EPS -2.2
Dividend 0
Relative Strength Index 34.46
Money Flow Index 61.92
MACD Signal -3.06
Average True Range 3.75

Lyka Labs Investment Rating

  • Master Rating:
  • Lyka Labs has an operating revenue of Rs. 93.07 Cr. on a trailing 12-month basis. An annual revenue de-growth of -51% needs improvement, Pre-tax margin of -14% needs improvement, ROE of -28% is poor and needs improvement. The company has a high debt to equity of 140%, which can be a reason to worry. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 25 which is a POOR score indicating inconsistency in earnings, a RS Rating of 6 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C+ which is evident from recent supply seen, Group Rank of 104 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Institutional holding has remained stable in the last reported quarter. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Lyka Labs Financials
IndicatorMar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 1917222228
Operating Expenses Qtr Cr 1715171616
Operating Profit Qtr Cr 325612
Depreciation Qtr Cr 33339
Interest Qtr Cr 33333
Tax Qtr Cr 000013
Net Profit Qtr Cr -3-1000-15

Lyka Labs Technicals

EMA & SMA

Current Price
₹93.9
0.95 (1.02%)
  • Bullish Moving Average
  • ___
  • 2
  • Bearish Moving Average
  • ___
  • 14
  • 20 Day
  • ₹97.72
  • 50 Day
  • ₹103.76
  • 100 Day
  • ₹111.29
  • 200 Day
  • ₹119.02
  • 20 Day
  • ₹98.22
  • 50 Day
  • ₹103.11
  • 100 Day
  • ₹114.6
  • 200 Day
  • ₹124

Lyka Labs Resistance and Support

PIVOT
₹92.25
Resistance
First Resistance ₹94.7
Second Resistance ₹96.45
Third Resistance ₹98.9
RSI 34.46
MFI 61.92
MACD Single Line -3.06
MACD -3.47
Support
First Resistance ₹90.5
Second Resistance ₹88.05
Third Resistance ₹86.3

Lyka Labs Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 359,874 19,839,854 55.13
Week 285,686 14,475,720 50.67
1 Month 139,366 7,704,158 55.28
6 Month 114,281 6,374,590 55.78

Lyka Labs Result Highlights

Lyka Labs Synopsis

NSE-Medical-Generic Drugs

Lyka Labs is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 80.59 Cr. and Equity Capital is Rs. 30.69 Cr. for the Year ended 31/03/2023. Lyka Labs Ltd. is a Public Limited Listed company incorporated on 29/12/1976 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24230GJ1976PLC008738 and registration number is 008738.
Market Cap 311
Sales 81
Shares in Float 1.49
No of funds 15
Yield
Book Value 3.73
U/D Vol ratio 0.9
LTDebt / Equity 83
Alpha -0.09
Beta 0.99

Lyka Labs

Owner NameApr-23Mar-23Dec-22Sep-22
Promoters 54.56%51%47.59%47.59%
Mutual Funds 2.69%3.31%3.54%3.54%
Insurance Companies 0.4%0.43%0.46%0.46%
Foreign Portfolio Investors 0.17%0.18%0.37%0.57%
Financial Institutions/ Banks
Individual Investors 33.03%35.08%38.77%37.72%
Others 9.15%10%9.27%10.12%

Lyka Labs Management

Name Designation
Mr. Kunal N Gandhi Chairman & M.D & CEO
Mr. Yogesh B Shah Executive Director & CFO
Mrs. Nehal N Gandhi Non Executive Director
Mr. Vinod S Shanbhag Independent Director
Mr. Sandeep P Parikh Independent Director
Mrs. Dhara P Shah Independent Director

Lyka Labs Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Lyka Labs Corporate Action

Date Purpose Remarks
2023-05-23 Audited Results
2023-04-18 Others
2023-02-07 Quarterly Results
2023-01-21 Preferential issue of shares
2022-11-09 Quarterly Results

Lyka Labs MF Shareholding

Name Amount(cr)
Quant Active Fund Growth 4062

Lyka Labs FAQs

What is Share Price of Lyka Labs ?

Lyka Labs share price is ₹93 As on 29 May, 2023 | 20:26

What is the Market Cap of Lyka Labs ?

The Market Cap of Lyka Labs is ₹310.7 Cr As on 29 May, 2023 | 20:26

What is the P/E ratio of Lyka Labs ?

The P/E ratio of Lyka Labs is -23.4 As on 29 May, 2023 | 20:26

What is the PB ratio of Lyka Labs ?

The PB ratio of Lyka Labs is 6.8 As on 29 May, 2023 | 20:26

Q2FY23

Start Investing Now!

Open Free Demat Account in 5 mins

Enter Valid Mobile Number